JPS5738785A - 3-(hydroxy-1,2,4-triazinyl)thiomethylcephalosporin , manufacture and drug composition containing same - Google Patents
3-(hydroxy-1,2,4-triazinyl)thiomethylcephalosporin , manufacture and drug composition containing sameInfo
- Publication number
- JPS5738785A JPS5738785A JP10076481A JP10076481A JPS5738785A JP S5738785 A JPS5738785 A JP S5738785A JP 10076481 A JP10076481 A JP 10076481A JP 10076481 A JP10076481 A JP 10076481A JP S5738785 A JPS5738785 A JP S5738785A
- Authority
- JP
- Japan
- Prior art keywords
- thiomethylcephalosporin
- triazinyl
- hydroxy
- manufacture
- composition containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
- A61K47/552—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being an antibiotic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8014512A FR2485540A1 (en) | 1980-06-30 | 1980-06-30 | Cephalosporin(s) active against gram-negative bacteria - are 7- 2-2-amino-4-thiazolyl 2-methoxy-imino acetamido 3 hydroxy-1,2,4-triazinyl-thiomethyl 3-cephem 4-carboxylic acid 1-S-oxide(s) |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5738785A true JPS5738785A (en) | 1982-03-03 |
Family
ID=9243670
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10076481A Pending JPS5738785A (en) | 1980-06-30 | 1981-06-30 | 3-(hydroxy-1,2,4-triazinyl)thiomethylcephalosporin , manufacture and drug composition containing same |
JP10076581A Pending JPS5738786A (en) | 1980-06-30 | 1981-06-30 | Cephalosporin sulfoxide derivative, manufacture and drug composition containing it |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10076581A Pending JPS5738786A (en) | 1980-06-30 | 1981-06-30 | Cephalosporin sulfoxide derivative, manufacture and drug composition containing it |
Country Status (4)
Country | Link |
---|---|
JP (2) | JPS5738785A (en) |
AU (1) | AU7241081A (en) |
FR (1) | FR2485540A1 (en) |
ZA (2) | ZA814392B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4367228A (en) * | 1980-10-29 | 1983-01-04 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compound and composition |
DE3207840A1 (en) * | 1982-03-04 | 1983-09-15 | Hoechst Ag, 6230 Frankfurt | "CEPHALOSPORINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF" |
FR2546520B1 (en) * | 1983-05-27 | 1985-08-30 | Sanofi Sa | NOVEL ANTIBIOTIC COMPOUNDS DERIVED FROM CEPHALOSPORINS |
JP2007503447A (en) * | 2003-08-25 | 2007-02-22 | リヴァアックス ファーマスーティカルズ,エルエルシー | Neurotherapy Cefazolin Oral Administration Composition |
-
1980
- 1980-06-30 FR FR8014512A patent/FR2485540A1/en active Granted
-
1981
- 1981-06-29 ZA ZA814392A patent/ZA814392B/en unknown
- 1981-06-29 ZA ZA814394A patent/ZA814394B/en unknown
- 1981-06-30 JP JP10076481A patent/JPS5738785A/en active Pending
- 1981-06-30 JP JP10076581A patent/JPS5738786A/en active Pending
- 1981-06-30 AU AU72410/81A patent/AU7241081A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
FR2485540B1 (en) | 1984-02-24 |
ZA814392B (en) | 1982-07-28 |
ZA814394B (en) | 1982-09-29 |
JPS5738786A (en) | 1982-03-03 |
FR2485540A1 (en) | 1981-12-31 |
AU7241081A (en) | 1982-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH17516A (en) | Substituted iminodiacids,their preparation and pharmaceutical composition containing them | |
JPS5798281A (en) | Azabicyclooctane-carboxylic acid, manufacture and pharmaceutical composition containing same | |
JPS57102878A (en) | Novel 4,5-polymethylene-4-isothiazoline-3-one compound, manufacture and bactericide, medicine and cosmetic composition containing same | |
JPS5753473A (en) | Novel n-aryl-2-oxazolidinones, manufacture and drug containing them | |
JPS5731689A (en) | Substituted benzamide, manufacture and medicinal composition containing same | |
IL63368A0 (en) | 4,5-diaryl-alpha-polyfluoroalkyl-1h-imidazole-2-methanamines,their preparation and pharmaceutical compositions containing them | |
PH15791A (en) | Pharmaceutical composition containing 3,4-dihydro-3-oxoquinoxalines | |
PH16982A (en) | Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide and its pharmaceutical composition | |
IL62660A (en) | 4,5-diaryl-alpha(polyfluoroalkyl)-1h-pyrrole-2-methanamines,their preparation and pharmaceutical compositions containing them | |
IL64563A0 (en) | 3,4-bis-substituted 1,2,5-oxidiazole 2-oxides,their preparation and pharmaceutical compositions containing them | |
IL64252A (en) | 3,3-dimethyl-indolin-2-ones,their preparation and pharmaceutical compositions containing them | |
IL64416A (en) | N-cyclopropyloxyphenyl-n'-benzoylurea derivatives,process for the preparation thereof and insecticidal compositions containing them | |
IL62167A0 (en) | Phenoxy-aminopropanol derivatives,their manufacture and pharmaceutical compositions containing them | |
IL63145A (en) | Imidazothienopyrimidinedione derivatives,their manufacture and pharmaceutical compositions containing them | |
JPS57122084A (en) | Substituted benzamide, manufacture and pharmaceutical composition containing same | |
JPS5724365A (en) | Antitumoral compound, manufacture and medicinal composition containing same | |
JPS5750990A (en) | Condensed as-triazine derivative, manufacture and medicinal composition containing same | |
JPS5738785A (en) | 3-(hydroxy-1,2,4-triazinyl)thiomethylcephalosporin , manufacture and drug composition containing same | |
JPS5781493A (en) | Ammoniomethyl compound, manufacture and medicinal composition containing same | |
PH16754A (en) | Novel acylamino-benzazole derivatives,and pharmaceutical composition containing same | |
IL62592A0 (en) | Phenyl-quinolizidines,their manufacture and pharmaceutical compositions containing them | |
IL63595A0 (en) | Diaryl-imidazole compounds,their manufacture and pharmaceutical compositions containing them | |
IL63917A0 (en) | 2-aminoimidazoles,their manufacture and pharmaceutical compositions containing them | |
JPS56127340A (en) | Novel encephaline homologue, manufacture and medicinal composition | |
IL63572A0 (en) | Polyazaheterocyclic compounds,their manufacture and pharmaceutical compositions containing them |